CardioRenal Systems Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

CardioRenal Systems General Information

Description

Developer of medical devices designed to treat cardiac and vascular-related ailments. The company's devices rapidly removes contrast dyes that are known to be toxic to the kidneys to minimize the risk of under-hydration while maintaining the high urine flows recommended for the prevention of cervical intraepithelial neoplasm, enabling clinical practitioners to treat their patients suffering from acute renal failure in an improved way.

Contact Information

Formerly Known As
PLC Systems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 459 Fortune Boulevard
  • Milford, MA 01757
  • United States
+1 (508)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • 459 Fortune Boulevard
  • Milford, MA 01757
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioRenal Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Jan-2025 Completed Generating Revenue
4. Early Stage VC 12-Sep-2018 Completed Startup
3. Early Stage VC (Series A) 16-Mar-2017 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Buyout/LBO 14-May-2014 Completed Startup
To view CardioRenal Systems’s complete valuation and funding history, request access »

CardioRenal Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A1
To view CardioRenal Systems’s complete cap table history, request access »

CardioRenal Systems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to treat cardiac and vascular-related ailments. The company's devices rapidly remo
Therapeutic Devices
Milford, MA
36 As of 2026

Danvers, MA
 

Vapi, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CardioRenal Systems Competitors (12)

One of CardioRenal Systems’s 12 competitors is Abiomed, a Corporate Backed or Acquired company based in Danvers, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abiomed Corporate Backed or Acquired Danvers, MA
Meril Life Sciences Private Equity-Backed Vapi, India
Lumenis Private Equity-Backed Yokneam, Israel
Boston Scientific Corporation Marlborough, MA
Vascular Concepts Formerly PE-Backed Bangalore, India
You’re viewing 5 of 12 competitors. Get the full list »

CardioRenal Systems Patents

CardioRenal Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019222485-A2 Method and system to treat acute decompensated heart failure Inactive 18-May-2018
WO-2019222485-A3 Method and system to treat acute decompensated heart failure Inactive 18-May-2018
US-10881774-B2 Method and system to protect kidneys during surgery Inactive 23-Sep-2016
US-12064541-B2 Method and system to protect kidneys during surgery Active 23-Sep-2016
US-20180085510-A1 Method and system to protect kidneys during surgery Active 23-Sep-2016 A61M5/16804
To view CardioRenal Systems’s complete patent history, request access »

CardioRenal Systems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioRenal Systems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kidron Venture Capital Minority
Abiomed Corporation Minority
Exigent Capital Group Family Office Majority
Genesis Capital Advisors (New York) PE/Buyout Majority
To view CardioRenal Systems’s complete investors history, request access »

CardioRenal Systems FAQs

  • When was CardioRenal Systems founded?

    CardioRenal Systems was founded in 2014.

  • Where is CardioRenal Systems headquartered?

    CardioRenal Systems is headquartered in Milford, MA.

  • What is the size of CardioRenal Systems?

    CardioRenal Systems has 36 total employees.

  • What industry is CardioRenal Systems in?

    CardioRenal Systems’s primary industry is Therapeutic Devices.

  • Is CardioRenal Systems a private or public company?

    CardioRenal Systems is a Private company.

  • What is CardioRenal Systems’s current revenue?

    The current revenue for CardioRenal Systems is .

  • How much funding has CardioRenal Systems raised over time?

    CardioRenal Systems has raised $21.5M.

  • Who are CardioRenal Systems’s investors?

    Kidron, Abiomed, Exigent Capital Group, and Genesis Capital Advisors (New York) have invested in CardioRenal Systems.

  • Who are CardioRenal Systems’s competitors?

    Abiomed, Meril Life Sciences, Lumenis, Boston Scientific, and Vascular Concepts are some of the 12 competitors of CardioRenal Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process